CCR RE appoints new head of investment

CCR RE appoints new head of investment | Insurance Business Asia

Reinsurance

CCR RE appoints new head of investment

He brings 30 years of experience in responsible investing to the firm

Reinsurance

By
Kenneth Araullo

Sébastien Jallet (pictured) has been appointed as head of investment at CCR Re, where he will oversee the company’s investment portfolio. He will report directly to the executive management team.

Jallet, who holds a degree from the ENSAE school of economics, statistics, and finance, along with a postgraduate diploma in Probability from the University of Paris VI, previously served as head of investment for CCR for five years. In that role, he was also responsible for overseeing CCR Re’s investments.

His career also includes positions as head of fixed income insurance at Ostrum Asset Management and head of fixed income management at Generali Investment France.

Jallet began his career at Prepar Vie, a subsidiary of BRED Banque Populaire, where he held various roles.

CCR Re chief executive officer (CEO) Bertrand Labilloy commented on Jallet’s appointment, highlighting his 30 years of management experience with major insurance companies and his background in responsible investing as key assets for CCR Re’s future success.

Back in May, the reinsurer also announced the appointment of Cédric Boureau as senior actuary underwriter. Boureau handles underwriting for the Asia and Africa regions, reporting to John Conan.

Boureau returned to CCR Re after four years at Swiss Re, where he served as reinsurance senior client treaty underwriter (non-life) for France, Belgium, and Luxembourg.

In April, the firm also shared its 2023 Activity Report, highlighting a year marked by substantial growth and strategic enhancements.

The company noted that it is set to progress into 2024 buoyed by favorable market conditions and a strengthened partnership with its shareholders.

In 2023, CCR Re completed a significant transaction involving the acquisition of the company and a concurrent capital infusion by the mutual insurance groups SMABTP and MACSF. This move, the company explained, underscores the reinsurance firm’s promising growth trajectory amid a dynamic market environment.

What are your thoughts on this story? Please feel free to share your comments below.